Clinical Trial Update: Efficacy and Tolerability of Two Different Administration Routes With SLITonePLUS Birch [Phase 2]

View source ↗

Summary

Phase 2 study evaluating efficacy and tolerability of two administration routes for SLITonePLUS Birch in birch pollen–related allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Birch Pollen Allergy

Drugs mentioned

• SLITonePLUS Birch (birch pollen extract)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergy | Phase 2 | Status: COMPLETED